CAPRICOR THERAPEUTICS, INC. Operating Income Loss

• CAPRICOR THERAPEUTICS, INC. showed a decrease of -154.1% in Operating Income Loss from 2024 to 2025.
• This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), CAPRICOR THERAPEUTICS, INC.'s Operating Income Loss has declined by 1,618.3%.
• Historical annual values: Fiscal year 2025: -$108.14 million | Fiscal year 2024: -$42.56 million | Fiscal year 2023: -$24.08 million | Fiscal year 2022: -$29.70 million | Fiscal year 2021: -$20.94 million | Fiscal year 2020: -$13.69 million | Fiscal year 2019: -$7.73 million | Fiscal year 2018: -$15.33 million | Fiscal year 2017: -$12.86 million | Fiscal year 2016: -$16.98 million | Fiscal year 2015: -$12.61 million | Fiscal year 2014: -$6.02 million | Fiscal year 2013: -$6.90 million | Fiscal year 2012: -$2.10 million | Fiscal year 2011: -$4.90 million | Fiscal year 2010: -$6.29 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026